Novartis and Roche, linked since Novartis took a stake in 2001, are speculated to consider a $440 billion tie-up due to Roche's recent misfortune and low share price. Aimee Donnellan argues that the logic of a combination is now more convincing, given the companies' divergent fortunes. Private credit lenders, led by Goldman Sachs, have agreed to provide $1.4 billion of debt to help EQT finance its acquisition of medical device firm Zeus.
On @Breakingviews: In 2001, Novartis took a stake in Roche and sparked speculation of a possible merger that never panned out. But the groups’ divergent fortunes mean the logic of a combination is now more convincing, says @aimeedonnellan https://t.co/xJSFT55uhS #BVPredicts
Novartis and Roche have been closely linked since the former took a stake in its rival in 2001. Roche’s recent misfortune and low share price opened the door for a $440 billion tie-up. However, getting the deal over the line will be tricky, argues Aimee Donnellan #BVPredicts https://t.co/OBj91swhuM
A relatively quick cure to Roche’s recent struggles will be a $440 billion tie-up with Novartis, a company it has been closely linked to since Novartis bought a stake in 2001. However, getting such a large deal over the line will be difficult, explains @aimeedonnellan #BVPredicts https://t.co/R6ibGprg7f
Novartis and Roche have been closely linked since the former took a stake in its rival in 2001. Roche’s recent misfortune and low share price opened the door for a $440 billion tie-up. However, getting the deal over the line will be tricky, argues @aimeedonnellan #BVPredicts https://t.co/AF2VnmlXt1
📺 Back in 2001 Novartis took a stake in Roche, sparking speculation of a possible merger that never panned out. But the groups’ divergent fortunes mean the logic of a combination could now be more convincing, says @aimeedonnellan. Watch 👉 https://t.co/z5xP16xT5F #BVPredicts https://t.co/GQWcXCUDHA
A group of private credit lenders led by Goldman Sachs has agreed to provide $1.4 billion of debt to help EQT finance its acquisition of medical device firm Zeus https://t.co/ih0eYEC8EO
On @Breakingviews: Back in 2001, Novartis took a stake in Roche and sparked speculation of a possible merger that never panned out. The companies’ divergent fortunes, however, mean that the logic of a combination is now more convincing, says @aimeedonnellan… https://t.co/HtsEeK76Rw